FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 27.7053

Change

+0.90 (+3.38)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+2.63 (+2.20%)

USD 15.96B
VOT Vanguard Mid-Cap Growth Index ..

+4.70 (+1.92%)

USD 14.56B
IJK iShares S&P Mid-Cap 400 Growth..

+1.35 (+1.48%)

USD 9.26B
XMMO Invesco S&P MidCap Momentum ET..

+2.51 (+2.06%)

USD 2.61B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+1.87 (+1.64%)

USD 1.09B
ETHO Amplify ETF Trust

+0.92 (+1.55%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+0.25 (+0.37%)

USD 0.18B
IPO Renaissance IPO ETF

+0.82 (+1.85%)

USD 0.15B
BFOR Barron's 400 ETF

+1.37 (+1.91%)

USD 0.15B
PEXL Pacer US Export Leaders ETF

+0.37 (+0.76%)

USD 0.06B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.69% 63% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.69% 63% D 67% D+
Trailing 12 Months  
Capital Gain 28.80% 67% D+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.80% 67% D+ 73% C
Trailing 5 Years  
Capital Gain -17.12% 39% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.12% 39% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain -1.69% 11% F 26% F
Dividend Return -1.02% 11% F 18% F
Total Return 0.67% 67% D+ 16% F
Risk Return Profile  
Volatility (Standard Deviation) 29.70% 28% F 35% F
Risk Adjusted Return -3.45% 11% F 21% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.